Autotransfusion Devices Market

Autotransfusion Devices Market
Global Analysis and Forecast to 2028
Published Date : Mar 2022
Email: sales@theinsightpartners.com

Email: sales@theinsightpartners.com
Report Studies
• Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global
Analysis By Type (Product and Accessories); Application (Cardiac Surgeries,
Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others); End
User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)
2

Email: sales@theinsightpartners.com
Autotransfusion Devices
Market Overview
• The Autotransfusion Devices Market is expected to grow from US$ 1,000.26 million in 2021
to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to
2028.
• Organ transplantation is a surgical procedure performed in case of organ failure. Usually,
organ transplantation is conducted for organs such as the heart, liver, and kidney; however,
with rising cases of chronic diseases, transplantation is needed for other organs such as
lungs, pancreas, cornea, and vascular tissues. These procedures generally take hours, and
there is a lot of blood loss, and autotransfusion is one of the valuable methods to prevent
blood loss. According to the United Network for Organ Sharing (UNOS), organ transplants
conducted in the US have continuously increased, with over 41,000 transplants performed in
2021. Similarly, according to World Transplant Registry data, Spain accounted for 20% of all
organ donations in the EU in 2019 and 6% of worldwide donations. Australia's organ donor
rate has improved in recent years, rising to 21.8 donors per million population in 2019.
3

Email: sales@theinsightpartners.com
Key Segment Market
Segment By Type:-
• By Type (Product and Accessories)
• Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma
Procedures, and Others)
• End-User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)
Download Sample
Here
4

Email: sales@theinsightpartners.com
Autotransfusion
Devices Market
Value
CAGR of 4.2%
(2021 - 2028)
$50,000
$40,000
$30,000
$20,000
$10,000
$0
20XX 20XX 20XX 20XX 20XX
Download Sample
5

Email: sales@theinsightpartners.com
Company Profiles
• BD
• Braile Biomedica
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• LivaNova PLC
• Medtronic
• Redax S.p.A.
• SARSTEDT AG and Co. KG
• Teleflex Incorporated
• Zimmer Biomet
Download Sample
Here
6

Email: sales@theinsightpartners.com
By Geography
• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)
• Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)
• South & Central America (Brazil, Argentina, and the Rest of South & Central America).
7

THANK
YOU!
Phone : +1-646-491-9876
E-Mail : sales@theinsightpartners.com